Pfizer’s Buried Data Bolsters Links Between Inflammation & Alzheimer’s Disease
A team of Pfizer researchers found Enbrel, a powerful anti-inflammatory, appeared to reduce the risk of Alzheimer’s Disease (AD) by 64% according to The Boston Globe. The company declined to invest the $80 million required to put the...
Study Finds New Brain Cells Develop into Our Nineties
Discoveries in recent years have shown that, contrary to popular belief, neurogenesis—the growth and development of new neurons—can occur into adulthood. But now a new study from the University of Illinois at Chicago finds that new...
Rejenevie™ Immune Restoration Therapy Approved for Phase II Clinical Trial at Okyanos
HOUSTON, May 29, 2019 — Rejenevie™ Therapeutics announced the start of its phase two clinical trial to study the safety and effectiveness of its proprietary AR-100 immune restoration therapy today. The therapy, which is administered at...
‘Inflamm-aging’ Slows Healing of Injured Bones as We Age
April 10, 2019 — A new study published in the Proceedings of the National Academy of Sciences (PNAS) finds that an increase in chronic inflammation is the reason injured bones do not heal as well with age. The study explains that ......
Dr. Matthew Stiebel Speaks at the Fifth International Knee Update
Davos, Switzerland, April 6, 2019 — Matthew Stiebel, MD spoke at the fifth International Knee Update in Davos, Switzerland yesterday. Dr. Stiebel, a board certified orthopedic specialist from Palm Beach and a treating physician at the...
Okyanos Center For Regenerative Medicine Treats Military Veterans With Stem Cell Therapy For Traumatic Brain Injury (TBI) And Chronic Pain Due To Orthopedic Injuries
Many of those treated are highly decorated Green Berets and Navy Seals who served multiple deployments in Iraq and Afghanistan FREEPORT, Bahamas, April 3, 2019 — Twenty-four U.S. military veterans suffering from traumatic brain...
Parkinson’s In The News
An article published in the Journal of Parkinson’s Disease says newly developed stem cell technologies show great promise in treating the disease over the next two decades. Parkinson’s is the second most common neurodegenerative...
Okyanos Global Health CEO Dr. Marc Penn featured on Worldwide Business with kathy ireland®
Los Angeles, CA (February 12, 2019) – Okyanos Global Health CEO Dr. Marc Penn discusses stem cell therapies offered at Okyanos Center for Regenerative Medicine on the internationally syndicated series, Worldwide Business with kathy...
Stem Cell Research: Lupus A New POC Study
The Lupus Foundation of America spotlights a proof of concept (POC) study out of Spain that shows promising results for stem cell therapy treatment. The study captured results using mesenchymal stem cells (MSCs) to treat lupus...
Okyanos Executive Fiona Daniels Takes on Community Leadership Role in Grand Bahama
Okyanos is proud to acknowledge Mrs. Fiona Daniels, Director of Finance & Administration, for her recent appointment to the 2018 Board of Directors for the Grand Bahama Chamber of Commerce. Since its inception in 1981, the...
Dr. W. E. “Ed” Bosarge Receives the 2018 Leadership Award at the World Stem Cell Summit (WSCS) in Miami, Florida
FOUNDER AND CHAIRMAN OF BLACK BERET LIFE SCIENCES, LLC IS LAUDED FOR HIS LEADERSHIP ROLE IN ADVANCING REGENERATIVE MEDICINE Miami, Florida (Jan. 24, 2018) – Dr. W. E. “Ed” Bosarge, the Founder and Chairman of Black Beret Life Sciences...
Okyanos Center for Regenerative Medicine Announces New Treatment Option for Diffuse Scleroderma Based on STAR Trial Protocol
Freeport, Grand Bahama (October 4, 2017) – Okyanos Center for Regenerative Medicine today announced that Okyanos is now offering a new and advanced protocol for diffuse scleroderma based on the well-established protocol implemented in...
- 1
- 2